初级保健对挪威国家抗微生物药物耐药性战略的看法。
The Primary Care Perspective on the Norwegian National Strategy against Antimicrobial Resistance.
作者信息
Rørtveit Guri, Simonsen Gunnar Skov
机构信息
Department of Global Public Health and Primary Care, University of Bergen, 07103 Bergen, Norway.
Department of Microbiology and Infection Control, University Hospital of North Norway, 9019 Tromsø, Noway.
出版信息
Antibiotics (Basel). 2020 Sep 19;9(9):622. doi: 10.3390/antibiotics9090622.
Abstract
A national strategy to combat antimicrobial resistance (AMR) has been subject to cyclic processes in Norway since 1998. In 2020, a renewed process cycle was launched. Here, we describe the process and the approach of the process. In addition, we describe two concepts from philosophy of science that may help to frame the process: AMR is an example of a super wicked problem, and post-normal science provides tools to analyze the problem from a new angle.
摘要
自1998年以来，挪威一项抗击抗菌药物耐药性（AMR）的国家战略经历了循环过程。2020年，启动了一个新的流程周期。在此，我们描述该流程及其方法。此外，我们描述了科学哲学中的两个概念，它们可能有助于构建该流程：AMR是一个超级棘手问题的例子，而后常规科学提供了从新角度分析该问题的工具。
相似文献
1
The Primary Care Perspective on the Norwegian National Strategy against Antimicrobial Resistance.初级保健对挪威国家抗微生物药物耐药性战略的看法。
Antibiotics (Basel). 2020 Sep 19;9(9):622. doi: 10.3390/antibiotics9090622.
2
Antimicrobial resistance as a super wicked problem: how do we engage the public to be part of the solution.抗菌药物耐药性作为一个超级棘手的问题：我们如何让公众参与进来成为解决方案的一部分。
Infect Prev Pract. 2023 Nov 14;5(4):100314. doi: 10.1016/j.infpip.2023.100314. eCollection 2023 Dec.
3
Something Borrowed, Something New: A Governance and Social Construction Framework to Investigate Power Relations and Responses of Diverse Stakeholders to Policies Addressing Antimicrobial Resistance.借来之物，新生之事：一个治理与社会建构框架，用于调查权力关系以及不同利益相关者对解决抗菌药物耐药性政策的反应。
Antibiotics (Basel). 2018 Dec 24;8(1):3. doi: 10.3390/antibiotics8010003.
4
System Mapping of Antimicrobial Resistance to Combat a Rising Global Health Crisis.对抗日益严重的全球健康危机的抗菌药物耐药性系统映射。
Front Public Health. 2022 Jun 17;10:816943. doi: 10.3389/fpubh.2022.816943. eCollection 2022.
5
Appraising Nigeria's approach to combating antimicrobial resistance.评估尼日利亚对抗抗菌药物耐药性的方法。
Int J Health Plann Manage. 2024 Mar;39(2):556-562. doi: 10.1002/hpm.3717. Epub 2023 Oct 16.
6
Less Is More: Norwegian Drug Regulation, Antibiotic Policy, and the "Need Clause".少即是多：挪威的药品监管、抗生素政策与“需求条款”。
Milbank Q. 2019 Sep;97(3):762-795. doi: 10.1111/1468-0009.12405. Epub 2019 Jul 21.
7
A proposed analytic framework for determining the impact of an antimicrobial resistance intervention.一个用于确定抗菌药物耐药性干预措施影响的拟议分析框架。
Anim Health Res Rev. 2017 Jun;18(1):1-25. doi: 10.1017/S1466252317000019. Epub 2017 May 16.
8
Measures Against Antimicrobial Resistance in Children in Japan: Current Status and Future Prospects.日本儿童抗菌药物耐药对策：现状与展望。
Pediatr Infect Dis J. 2022 Sep 1;41(9):e383-e387. doi: 10.1097/INF.0000000000003612. Epub 2022 Jun 21.
9
Antimicrobial susceptibility and clonality of Streptococcus pneumoniae isolates recovered from invasive disease cases during a period with changes in pneumococcal childhood vaccination, Norway, 2004-2016.2004年至2016年挪威肺炎球菌儿童疫苗接种发生变化期间，从侵袭性疾病病例中分离出的肺炎链球菌菌株的抗菌药敏性和克隆性
Vaccine. 2020 Jul 22;38(34):5454-5463. doi: 10.1016/j.vaccine.2020.06.040. Epub 2020 Jun 30.
10
Comparative Genome Sequence Analysis of Serovar 8 Isolates From Norway, Denmark, and the United Kingdom Indicates Distinct Phylogenetic Lineages and Differences in Distribution of Antimicrobial Resistance Genes.对来自挪威、丹麦和英国的8型血清型分离株进行的比较基因组序列分析表明，存在不同的系统发育谱系以及抗菌药物耐药基因分布的差异。
Front Microbiol. 2021 Sep 10;12:729637. doi: 10.3389/fmicb.2021.729637. eCollection 2021.
引用本文的文献
1
Quantifying antimicrobial resistance in food-producing animals in North America.量化北美食用动物中的抗菌素耐药性。
Front Microbiol. 2025 May 27;16:1542472. doi: 10.3389/fmicb.2025.1542472. eCollection 2025.
2
Antibiotic prescriptions among dentists across Norway and the impact of COVID-19 pandemic.挪威各地牙医的抗生素处方和 COVID-19 大流行的影响。
BMC Oral Health. 2023 Sep 8;23(1):649. doi: 10.1186/s12903-023-03380-6.
3
Antibiotics for gastroenteritis in general practice and out-of-hour services in Norway 2006-15.2006-2015 年挪威一般医疗实践和非工作时间服务中治疗肠胃炎的抗生素使用情况。
Fam Pract. 2022 Jan 19;39(1):19-25. doi: 10.1093/fampra/cmab080.
4
Consultations and antibiotic treatment for urinary tract infections in Norwegian primary care 2006-2015, a registry-based study.2006-2015 年挪威初级保健中尿路感染的咨询和抗生素治疗：一项基于登记的研究。
BMC Fam Pract. 2021 Jun 24;22(1):127. doi: 10.1186/s12875-021-01470-4.
本文引用的文献
1
Serious bacterial infections and antibiotic prescribing in primary care: cohort study using electronic health records in the UK.初级保健中的严重细菌感染和抗生素处方：英国电子健康记录的队列研究。
BMJ Open. 2020 Feb 28;10(2):e036975. doi: 10.1136/bmjopen-2020-036975.
2
Antimicrobial resistance is a super wicked problem.抗微生物药物耐药性是一个超级棘手的问题。
Tidsskr Nor Laegeforen. 2019 Oct 31;139(16). doi: 10.4045/tidsskr.19.0478. Print 2019 Nov 5.
3
Penicillin V four times daily for five days versus three times daily for 10 days in patients with pharyngotonsillitis caused by group A streptococci: randomised controlled, open label, non-inferiority study.青霉素 V 每日 4 次，连用 5 天，与每日 3 次，连用 10 天，治疗 A 组链球菌引起的咽扁桃体炎：随机对照、开放标签、非劣效性研究。
BMJ. 2019 Oct 4;367:l5337. doi: 10.1136/bmj.l5337.
4
Reducing antibiotic prescribing in primary care in England from 2014 to 2017: population-based cohort study.2014 年至 2017 年在英格兰减少初级保健中的抗生素处方：基于人群的队列研究。
BMJ Open. 2019 Jul 9;9(7):e023989. doi: 10.1136/bmjopen-2018-023989.
5
Decreasing trends, and geographical variation in outpatient antibiotic use: a population-based study in Central Denmark.丹麦中部地区基于人群的研究显示，门诊抗生素使用呈下降趋势且存在地域差异。
BMC Infect Dis. 2019 Apr 24;19(1):337. doi: 10.1186/s12879-019-3964-9.
6
7
Public health burden of antimicrobial resistance in Europe.欧洲抗菌药物耐药性的公共卫生负担
Lancet Infect Dis. 2019 Jan;19(1):4-6. doi: 10.1016/S1473-3099(18)30648-0. Epub 2018 Nov 5.
8
Antimicrobial Resistance: a One Health Perspective.抗微生物药物耐药性：一种从“同一健康”角度看问题的方式。
Microbiol Spectr. 2018 Mar;6(2). doi: 10.1128/microbiolspec.ARBA-0009-2017.
9
The antibiotic course has had its day.抗生素疗程已经过时了。
BMJ. 2017 Jul 26;358:j3418. doi: 10.1136/bmj.j3418.
10
Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050?到2050年，每年会有1000万人死于抗微生物药物耐药性吗？
PLoS Med. 2016 Nov 29;13(11):e1002184. doi: 10.1371/journal.pmed.1002184. eCollection 2016 Nov.
Zotero 插件